Companies: 10,795·Total market cap: $144.5T
Restart Life Sciences Corp.

Restart Life Sciences Corp.

NMLSFOTCHealthcare● Active
$0.04
+$0.00(+0.00%)
Market Cap$1279264
P/E Ratio
52W High$0.12422
52W Low$0.0101
Overview

Restart Life Sciences Corp. (NMLSF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · NMLSF · as of Jun 15, 2026

Key Statistics

EPS (TTM)$-0.01nmlsf eps ttm · nmlsf earnings per shareEarnings history
PE Ratio (TTM)nmlsf pe ratio ttm · nmlsf price to earningsPE Ratio deep dive
Revenue (TTM)134899.00nmlsf revenue ttm · nmlsf annual revenueFull revenue history
Dividend YieldNo Dividenddoes nmlsf pay dividends · nmlsf dividend yieldDividend history
Shares Outstanding3.39Bnmlsf shares outstanding · nmlsf floatShares outstanding history
Next EarningsTBAnmlsf earnings date · nmlsf next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
restart life sciences corp. revenue · nmlsf revenue 2025
FY 2025Net Income-$1.4M▼ 718.72% YoY
202320242025
restart life sciences corp. net income · nmlsf profit 2025
FY 2025EPS$-0.00▼ 102.72% YoY
202320242025
nmlsf eps · restart life sciences corp. earnings per share 2025
TTM:Revenue: $134899.00Net Income: -$898770.00EPS: $-0.01View income statement →

Stock Performance

Full History
1D+0.00%
1W+65.09%
1M-29.72%
3M-51.55%
YTD-59.53%
1Y-24.08%
5Y-95.39%

About Restart Life Sciences Corp.

CEOSteve Loutskou
IPO DateJun 27, 2008
Employees
CountryCA

Restart Life Sciences Corp. functions as a biotechnology firm, with its primary focus being the exploration and advancement of psilocybin. The company's offerings encompass therapeutic treatments and …

what is restart life sciences corp. · nmlsf stock overview · restart life sciences corp. company profile · who is restart life sciences corp. ceo · nmlsf OTC · restart life sciences corp. headquarters · restart life sciences corp. business segments

About Stock Overview & Key Data

Restart Life Sciences Corp. (NMLSF) is a Healthcare company in the Biotechnology industry, listed on OTC since Jun 27, 2008. As of the latest trading session, NMLSF stock price is $0.04, with a market capitalization of $1.3M. The stock has returned -24.08% over the past 12 months and -59.53% year-to-date.

In fiscal year 2025, Restart Life Sciences Corp. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Restart Life Sciences Corp. (NMLSF) stock price is $0.04. The stock is traded on OTC under the ticker symbol NMLSF. The 52-week range is $0.01 – $0.12.

NMLSF stock priceNMLSF quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 15, 2026Not investment advice